HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiang Qin Selected Research

Therapeutics

10/2023Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial.
10/2023Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial.
2/2023Bio-inspired Oxidative Stress Amplifier for Suppressing Cancer Metastasis and Imaging-Guided Combination Therapy.
12/2022Polydopamine-Engineered Theranostic Nanoscouts Enabling Intracellular HSP90 mRNAs Fluorescence Detection for Imaging-Guided Chemo-Photothermal Therapy.
11/2022Shear stress enhances anoikis resistance of cancer cells through ROS and NO suppressed degeneration of Caveolin-1.
9/2022Tumor homing-penetrating and nanoenzyme-augmented 2D phototheranostics against hypoxic solid tumors.
3/2022Cascade-activatable NO release based on GSH-detonated "nanobomb" for multi-pathways cancer therapy.
1/2022Non-muscle myosin II isoforms orchestrate substrate stiffness sensing to promote cancer cell contractility and migration.
1/2022Caveolin-1 controls mitochondrial damage and ROS production by regulating fission - fusion dynamics and mitophagy.
1/2022Pharmacological Activation of Potassium Channel Kv11.1 with NS1643 Attenuates Triple Negative Breast Cancer Cell Migration by Promoting the Dephosphorylation of Caveolin-1.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiang Qin Research Topics

Disease

48Neoplasms (Cancer)
11/2023 - 01/2014
21Multiple Myeloma
10/2023 - 05/2013
13Breast Neoplasms (Breast Cancer)
10/2023 - 01/2018
6Neoplasm Metastasis (Metastasis)
02/2023 - 09/2017
5Disease Progression
10/2023 - 10/2016
5Infections
10/2021 - 05/2013
4Amyloidosis
11/2022 - 01/2021
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2022 - 06/2021
3Immunoglobulin Light-chain Amyloidosis
04/2023 - 01/2020
3Triple Negative Breast Neoplasms
01/2022 - 01/2020
3COVID-19
01/2021 - 07/2020
3Neutropenia
01/2020 - 08/2016
3Thrombocytopenia (Thrombopenia)
01/2020 - 08/2016
3Castleman Disease (Castleman's Disease)
10/2015 - 08/2010
2Non-alcoholic Fatty Liver Disease
02/2024 - 01/2022
2Chromosome Aberrations (Chromosome Abnormalities)
10/2023 - 10/2023
2Hyperthermia
02/2023 - 10/2021
2Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 11/2021
2Liver Neoplasms (Liver Cancer)
10/2021 - 01/2021
2Pain (Aches)
01/2021 - 10/2015
2Lymphopenia (Lymphocytopenia)
01/2021 - 10/2015
2Residual Neoplasm
01/2021 - 10/2016
2Anemia
10/2016 - 08/2016
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
10/2016 - 03/2015
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2015 - 08/2010
2Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2015 - 07/2013
2Inflammation (Inflammations)
03/2014 - 01/2013
1Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2024
1Dyslipidemias (Dyslipidemia)
02/2024
1Diabetes Mellitus
02/2024
1Obesity
02/2024
1Hypertension (High Blood Pressure)
02/2024
1Fatty Liver
01/2024
1Necrosis
10/2023
1Rupture
06/2023

Drug/Important Bio-Agent (IBA)

19daratumumabIBA
10/2023 - 08/2016
17Dexamethasone (Maxidex)FDA LinkGeneric
10/2023 - 05/2013
13Bortezomib (Velcade)FDA Link
10/2023 - 05/2013
8Therapeutic UsesIBA
02/2024 - 03/2015
8siltuximabIBA
01/2019 - 08/2010
7Lenalidomide (CC 5013)FDA Link
10/2023 - 10/2016
7Interleukin-6 (Interleukin 6)IBA
01/2019 - 08/2010
7Monoclonal AntibodiesIBA
08/2016 - 08/2010
6Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2018
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2023 - 01/2020
5Caveolin 1IBA
11/2022 - 01/2019
4Photosensitizing Agents (Photosensitizers)IBA
02/2023 - 01/2019
4OligonucleotidesIBA
01/2021 - 01/2019
3polyacrylamideIBA
10/2023 - 01/2019
3Glutathione (Reduced Glutathione)IBA
02/2023 - 01/2021
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 01/2019
3Amyloid (Amyloid Fibrils)IBA
11/2022 - 01/2021
31-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2022 - 03/2018
3IntegrinsIBA
01/2020 - 07/2018
2Proteasome InhibitorsIBA
10/2023 - 05/2020
2Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
04/2023 - 01/2021
2NanovaccinesIBA
03/2023 - 10/2022
2Silicon Dioxide (Silica)FDA LinkGeneric
02/2023 - 01/2019
2AntioxidantsIBA
02/2023 - 01/2022
2AcidsIBA
01/2023 - 01/2020
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 02/2018
2Actins (F Actin)IBA
11/2022 - 01/2021
2MicellesIBA
10/2022 - 11/2019
2OvalbuminIBA
10/2022 - 03/2014
2Peptides (Polypeptides)IBA
09/2022 - 01/2021
2Oxygen (Dioxygen)IBA
09/2022 - 02/2020
2Singlet OxygenIBA
09/2022 - 11/2021
2Deoxyglucose (2 Deoxy D glucose)IBA
07/2022 - 11/2021
2Lovastatin (Mevacor)FDA LinkGeneric
07/2022 - 11/2021
2Messenger RNA (mRNA)IBA
06/2022 - 01/2019
2Polysaccharides (Glycans)IBA
01/2022 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
2MicroRNAs (MicroRNA)IBA
01/2022 - 10/2020
2Protein Isoforms (Isoforms)IBA
01/2022 - 01/2019
2Adenosine Triphosphate (ATP)IBA
11/2021 - 08/2018
2AntibodiesIBA
10/2021 - 01/2016
2DNA (Deoxyribonucleic Acid)IBA
10/2021 - 01/2015
2Contrast MediaIBA
01/2021 - 08/2018
2GraphiteIBA
01/2020 - 01/2019
2CytokinesIBA
01/2019 - 02/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2018 - 01/2016
2IgYIBA
01/2016 - 03/2014
1naringinIBA
02/2024
1MicronutrientsIBA
01/2024
1Myosins (Myosin)IBA
11/2023
1AminopropionitrileIBA
10/2023
1CalciumIBA
10/2023
11,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl esterIBA
06/2023
1Chelating AgentsIBA
06/2023
1polydopamineIBA
02/2023
1ZincIBA
02/2023

Therapy/Procedure

30Therapeutics
10/2023 - 05/2013
6Immunotherapy
03/2023 - 02/2018
6Precision Medicine
12/2022 - 01/2019
5Photothermal Therapy
02/2023 - 02/2018
5Photochemotherapy (Photodynamic Therapy)
02/2023 - 02/2018
5Drug Therapy (Chemotherapy)
01/2023 - 08/2018
5Lasers (Laser)
09/2022 - 02/2018
2Aftercare (After-Treatment)
02/2023 - 09/2011
2Catheters
10/2016 - 03/2015